<SEC-DOCUMENT>0001654954-23-007195.txt : 20230525
<SEC-HEADER>0001654954-23-007195.hdr.sgml : 20230525
<ACCEPTANCE-DATETIME>20230525082442
ACCESSION NUMBER:		0001654954-23-007195
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230525
DATE AS OF CHANGE:		20230525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inuvo, Inc.
		CENTRAL INDEX KEY:			0000829323
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-ADVERTISING [7310]
		IRS NUMBER:				870450450
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253018
		FILM NUMBER:		23956262

	BUSINESS ADDRESS:	
		STREET 1:		500 PRESIDENT CLINTON AVE., STE. 300
		CITY:			LITTLE ROCK
		STATE:			AR
		ZIP:			72201
		BUSINESS PHONE:		501-205-8508

	MAIL ADDRESS:	
		STREET 1:		500 PRESIDENT CLINTON AVE., STE. 300
		CITY:			LITTLE ROCK
		STATE:			AR
		ZIP:			72201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INUVO, INC.
		DATE OF NAME CHANGE:	20090810

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KOWABUNGA! INC.
		DATE OF NAME CHANGE:	20081106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THINK PARTNERSHIP INC
		DATE OF NAME CHANGE:	20060315
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>inuvo_424b5.htm
<DESCRIPTION>FORM 424B5
<TEXT>
<html><head><title>inuvo_424b5.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Filed Pursuant to Rule 424(b)(5)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Registration&nbsp;No.&nbsp;333-253018</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>PROSPECTUS SUPPLEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">(To the Prospectus dated March 15, 2021)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>$9,533,973</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="inuvo_424b3img2.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Inuvo, Inc.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Common Stock</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">This prospectus supplement amends and supplements the information in our prospectus dated March 15, 2021, as supplemented, which form a part of our Registration Statement on Form S-3 (File&nbsp;No.&nbsp;333-253018), or the Prospectus.&nbsp;This prospectus supplement should be read in conjunction with the Prospectus and is qualified in its entirety by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prospectus supplemented. This prospectus supplement is not complete without, and may only be delivered or utilized in connection with, the Prospectus and any future amendments or supplements thereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">We filed the Prospectus to register the offer and sale of shares of our common stock from time to time pursuant to the terms of a sales agreement, dated May 28, 2021, or the Sales Agreement, that we entered into with A.G.P./Alliance Global Partners, or A.G.P., as our sales agent thereunder. As of the date of this prospectus supplement, we have sold 173,000 shares of our common stock through A.G.P. under the Sales Agreement totaling proceeds of&nbsp;$63,197. Without giving effect to any offering limit imposed by General Instruction I.B.6 of Form&nbsp;S-3,&nbsp;we may offer and sell shares of our common stock having an aggregate offering price of up to $35,000,000 from time to time through A.G.P. acting as our sales agent in accordance with the terms of the&nbsp;Sales Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As of May 23, 2023, the aggregate market value of our outstanding common stock held by&nbsp;non-affiliates,&nbsp;or public float, was approximately $40,985,811, based on 121,815,013 shares of our outstanding common stock that were held by&nbsp;non-affiliates&nbsp;and a price of $0.37 per share, which was the price at which our common stock was last sold on NYSE American on May 23, 2023 (a date within 60 days of the date hereof), calculated in accordance with General Instruction I.B.6 of Form&nbsp;S-3.&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">We are filing this prospectus supplement to amend and supplement the information in our Prospectus to reduce the maximum aggregate offering price of our common stock that may be offered, issued and sold under the Sales Agreement.&nbsp;Accordingly, we may offer and sell shares of our common stock having an aggregate offering price of up to $9,533,973 from time to time through A.G.P. acting as our sales agent in accordance with the terms of the&nbsp; Sales Agreement. Upon any sale of shares of our common stock under this prospectus supplement pursuant to General Instruction I.B.6 of Form S-3, in no event will the aggregate market value of securities sold by us or on our behalf pursuant to General Instruction I.B.6 of Form S-3 during the 12 calendar month period immediately prior to, and including, the date of any such sale exceed one-third of the aggregate market value of our shares of common stock held by non-affiliates, calculated in accordance with General Instruction I.B.6 of Form S-3.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Our common stock is listed on NYSE American under the symbol &#8220;INUV.&#8221; On May 24, 2023, the last reported sale price of our common stock on NYSE American was $0.36 per share.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Investing in our securities involves risks. You should read this prospectus supplement and the documents we incorporate herein by reference carefully before you make your investment decision. See &#8220;Risk Factors&#8221; set forth in the documents we file with the Securities and Exchange Commission that are incorporated by reference herein for more information.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">A.G.P.</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>The date of this prospectus supplement is May 25, 2023</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>inuvo_424b3img2.jpg
<TEXT>
begin 644 inuvo_424b3img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  ] , # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#UGXI_'"\^
M'OC&#08='CNUEC5][,>]>R:9=_VCI5I?;-OGQK+CTR*HZIX4\.:U=)=:KH]M
M=S+]UY4R:UXXHX8DBC7:B#  [4 2T444 %%%% "5EZQJ9TNQ:Y6+S,'I6IVJ
M.2*.9-LB!AZ&L*T9RC:#LP.,_P"$SE_Y\3^=+_PF4W_/F/SKJO[-L_\ GW3\
MJ/[-L_\ GW3\J\KZOB/YB.67<Y/_ (3*7_GSH_X3-_\ GTKK/[-L_P#GW3\J
M/[-L_P#GW3\JGZMB/Y@Y9=S-T+76UCSMT/E[*W^]016\$'^JC5,^@J;M7K4(
M5(0M4=V6+11170 4444 %%%% !1110 4444 ?/7QT^*GBSP+XDT^QT"6".&:
M/<_FINR:]>T[5KZ\^'-OK"KYE_)8^=M ^])M_P :^9OVI_\ D=-)_P"N(KZ<
M\"_\D_T+_KU3^5 'RM?_ !V^,&@W&[5]+2!-_P BS6^T.!_#7OZ?%W1;/X3V
M7CC6E^S&ZCW); _,[_W5K@?VJ$5O"&CG8,_:37F/PM\':C\6=2L;75V>+P[H
M(V[4;AF_NT :NI?&?XM>-[QU\':5-:67\'V>/=N^K5C7'CCX^>%52\U=KV.%
M6^]<1[D7_9K[,TG1=+T.P2QTJRCM+=!@*BXJ34-/L]5T^;3[Z!)[>9"CHXSF
M@#RSX._&&'X@0/I6IPI:ZU;IN95/RRK_ 'EK9^+^O^+_  [X-6^\&6AN=0\Y
M5*"+?\M?,7AB'_A!?VH(M,M<K"E\UNJ_[#5]RT ?(7A?]H+Q[;^.++1O%%G%
MY,\RQ2(R;73-?7:-N16]1FOB[XMI&O[3EKM0+^^M^B_[5?9\/_'O'_NB@"2N
M>\8ZE=:+X*U?5;';]JM;9Y(]W3=70UR?Q'_Y)CXB_P"O.3^5 'F'P#^)WBCQ
M_=ZQ%XC>%A;A3'Y2[=M<[\5?C#\1/ WQ$N;6QL4;1TV^4TL7ROZ\U1_9/_X_
MO$7^XG_H5>T_%WPK%XK^&FIV8C!NH8_.A;'(9: -;P#XNMO&_@RRU^W7RVF7
M$B?W'[UUE?*?[+?B9H+_ %;PC=2;=W[Z%#ZC[U?5E #'=8XR[G:JC)-?*'C'
M]H3QC/XVGT;P79Q-;03>4GR;WGKW7XM>*(_"?PSU34L_OG3R8AZLU>+_ +,/
MA3SY]3\9WL6X[O(A9Q_%U9EH ^CM'NKF3P[97FI;8KA[='FSP%;'->'?$C]H
MZST.]?1_!UNFI7J-L>X?_5*?;^]4_P"T=\1+CP]H%OX7TJX\J[U$9G=#\T<7
M_P!>J/P)^#5C::);>+?%%JMS?W \RWAE&51/X6(_O4 >?0^*/VAO%7^F6<%_
M#$?F7RH]BTX?%;XV>![J)O$=G-/;YVLMS#\K?\"K[+5%C0(BA5'0 53U+2M.
MU:RDL]3LX[JWD&&21=V: ///AG\9?#OQ$B^RJWV'5T'SVCMU_P!WUKU*OB7X
MM?#^\^$_C6S\1^%Y'@T^5]\#C_E@_P#$OTKZJ^'/B^'QOX#T_7D(\V5-LRC^
M%QUH ^;_ -J;_D==*^7_ )8"OISP+_R3_0O^O5/Y5\P_M3?\COI?_7 5]/>!
M_P#DGVA_]>:?RH \9_:K_P"1,TEO2YKJOV=])@TWX0V4\:;9+MVE=O[U<K^U
M9_R)6E?]?-=]\"_^2,Z+_N&@#TRBBB@#XI\6_P#)VR?]?Z5]J+]T5\5^+_\
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&,3=: /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
